MYX · Maywood Acquisition Corp. 2 Class A Ordinary Share

In this pre-IPO quarter ending March 31, 2026, the blank check company incurred operating income of -$4.8K under GAAP, reflecting unavoidable formation and initial operating costs as it readied for its April 2026 Initial Public Offering. These expenses represent the standard setup phase for special purpose acquisition companies, where administrative and preparatory activities drive losses before revenue generation from a Business Combination. Net income followed at -$4.6K, with net cash provided by operating activities mirroring this figure at -$4.6K, indicating that the net loss translated directly into cash usage without significant non-cash adjustments or working capital swings. Diluted EPS of $0.00 underscores the negligible per-share impact given the early-stage capital structure.

Liquidity remained thin but functional for this lifecycle stage. Management's discussion highlights reliance on sponsor support mechanisms, noting that co-sponsors or affiliates, along with officers and directors, may provide Working Capital Loans to cover transaction costs tied to pursuing a Business Combination target in any industry or geography. As of period-end, no such loans were outstanding, preserving flexibility without current repayment pressures. The company also reported no long-term debt, capital lease obligations, operating leases, or other long-term liabilities except for the described promissory note from Stone Bay, LLC, which minimizes fixed financial commitments during this pre-revenue period.

Post-IPO accounting treatment will allocate offering costs appropriately—those tied to equity-classified instruments against additional paid-in capital, and those for redeemable Class A ordinary shares to temporary equity—ensuring balance sheet integrity upon completion. This structured approach supports management's assertion that no substantial doubt exists about continuing as a going concern, as the forthcoming IPO proceeds are expected to provide the necessary capital infusion. Overall, Q1 results exemplify the predictable cost profile of a blank check entity in formation, with losses contained and pathways to future funding clearly outlined in Item 2's Liquidity and Capital Resources and Going Concern discussions.